Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Melita Kenealy"'
Autor:
Ing S. Tiong, William S. Stevenson, Meaghan Wall, Yan Zhuang Yap, John F. Seymour, Melita Kenealy, Piers Blombery, the Australasian Leukaemia & Lymphoma Group
Publikováno v:
eJHaem, Vol 4, Iss 4, Pp 1212-1215 (2023)
Externí odkaz:
https://doaj.org/article/84bfb8539c9b4cb39d8f404457cc07c4
Autor:
Melita Kenealy, Mark Hertzberg, Warwick Benson, Kerry Taylor, Ilona Cunningham, Will Stevenson, Devendra Hiwase, Richard Eek, Daniela Zantomio, Steve Jong, Meaghan Wall, Piers Blombery, Tracey Gerber, Marlyse Debrincat, Diana Zannino, John F. Seymour
Publikováno v:
Haematologica, Vol 104, Iss 4 (2019)
Standard treatment for higher risk myelodysplastic syndromes, chronic myelomonocytic leukemia and low blast acute myeloid leukemia is azacitidine. In single arm studies, adding lenalidomide had been suggested to improve outcomes. The ALLG MDS4 phase
Externí odkaz:
https://doaj.org/article/100c1073e6a747bdbc6ac870d32848d7
Autor:
Diva Baggio, Cameron Wellard, Eliza Chung, Dipti Talaulikar, Colm Keane, Stephen Opat, Pratyush Giri, Adrian Minson, Chan Yoon Cheah, Tasman Armytage, Denise Lee, Geoffrey Chong, Anna Johnston, Tara Cochrane, Neil Waters, Nada Hamad, Erica M. Wood, Eliza A. Hawkes, John Balendra, Allison Barraclough, Leanne Berkahn, Annmarie Bosco, Duncan Carradice, Hun Chuah, Luke Coyle, Kyle Crassini, Melita Kenealy, Matthew Ku, Teresa Leung, Kate Manos, Susan Morgan, Howard Mutsando, Manjunath Narayana, Emma Palfreymen, Miles Prince, Sumita Ratnasingam, Jock Simpson, Judith Trotman, Nicholas Viiala, Joel Wight
Publikováno v:
Leukemia & Lymphoma. 64:621-627
Autor:
John E. Pimanda, Julie A.I. Thoms, Henry R. Hampton, Sarah Davidson, Swapna Joshi, Chowdhury H. Sarowar, Xin Ying Lim, Andrea C. Nunez, Purvi M. Kakadia, Russell Pickford, Mark Raftery, Sally Hough, Griselda Buckland, Michelle Bailey, Yuvaraj Ghodke, Noorul Absar, Lachlin Vaughan, Leonardo Pasalic, Chun Yew Fong, Melita Kenealy, Devendra Hiwase, Rohanna Stoddart, Soma Mohammed, Linda Lee, Freda H. Passam, Kevin Spring, Kristy K. Skarratt, Patricia Rebeiro, Stephen R Larsen, Peter Presgrave, William S Stevenson, Silvia Ling, Campbell Tiley, Stephen Fuller, Fernando Roncolato, Anoop Kumar Enjeti, Dirk Hoenemann, Charlotte Lemech, Stefan K. Bohlander, Jake Olivier, Mark Hertzberg, Ashwin Unnikrishnan, Mark N. Polizzotto
Publikováno v:
Blood. 140:6927-6929
Autor:
Lynette Chee, David Ritchie, Mandy Ludford‐Menting, Jane Ripley, Jessica Chung, Daniel Park, Sam Norton, Melita Kenealy, Rachel Koldej
Publikováno v:
European Journal of Haematology. 108:342-353
Myelodysplastic syndromes (MDS) are characterised by ineffective haematopoiesis. Although hypomethylating agents (HMA) have improved survival in higher-risk MDS, most patients eventually succumb to progressive disease. Utilising samples collected pro
Autor:
Zoe K, McQuilten, Ljoudmila, Busija, John F, Seymour, Simon, Stanworth, Erica M, Wood, Melita, Kenealy, Robert, Weinkove
Publikováno v:
Leukemia & Lymphoma. 63:676-683
Myelodysplastic syndromes (MDS) have a major impact on quality of life (QoL). We performed a
Autor:
Ing S Tiong, William S Stevenson, Meaghan Wall, Yan Zhuang Yap, John F. Seymour, Melita Kenealy, Piers Blombery
Publikováno v:
Blood. 140:4090-4091
Autor:
Jeremy Millar, Kirsten Herbert, Ian E. Haines, H. Miles Prince, Susan Burney, Annette Graham, David W. Kissane, Robin E. Smith, Joanne Elizabeth Brooker, Karen Taylor, Ian Porter, Jane Madeline Fletcher, Melita Kenealy, Mark Frydenberg, John Julian
Publikováno v:
Palliative and Supportive Care. 18:130-140
ObjectivesPsychosocial interventions that mitigate psychosocial distress in cancer patients are important. The primary aim of this study was to examine the feasibility and acceptability of an adaptation of the Mindful Self-Compassion (MSC) program am
Autor:
Philip Campbell, Lugui Qiu, Jian Hou, Noemi Horvath, Michael Eisbacher, Sarah Siggins, Maximiliano van Kooten Losio, Anna Kalff, Melita Kenealy, Andrew Spencer, Douglas E. Joshua, Je-Jung Lee, H. Miles Prince, Anil Londhe, Tiffany Khong
Publikováno v:
Leukemia & Lymphoma. 60:2122-2133
Efficacy and safety of bortezomib-based consolidation following ASCT were investigated in newly diagnosed multiple myeloma patients from Australia, Korea, and China. Patients received three cycles of bortezomib-cyclophosphamide-dexamethasone inductio
Autor:
Warwick Benson, Tracey Gerber, Meaghan Wall, K. M. Taylor, Devendra K Hiwase, Piers Blombery, Richard Eek, Melita Kenealy, Diana Zannino, John F. Seymour, Marlyse A. Debrincat, Steve Jong, Mark P. Hertzberg, Daniela Zantomio, Will Stevenson, Ilona Cunningham
Publikováno v:
Haematologica
Standard treatment for higher risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast acute myeloid leukemia (AML) is azacitidine. In single arm studies, the addition of lenalidomide had been suggested to improve ou